Device Trial Radar · NCT07885176
Deep Repetitive Transcranial Magnetic Stimulation in the Treatment of Tinnitus
Last checked: Nov 19, 2026Latest source record: Oct 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
60
Planned (sponsor's estimate)
Start
Sep 19, 2026
Primary completion
Dec 31, 2028
Study completion Aug 31, 2029
Sponsor
- Lead sponsor
- University of RegensburgAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Oct 21, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Study of the efficacy of different H-coils in chronic tinnitus. Hypothesis: Active Deep repetitive transcranial magnetic stimulation deeprTMS reduces tinnitus distress more effectively than placebo stimulation. Randomized, placebo-controlled, parallel-group study with three treatment arms; additional comparison with a historical rTMS control group.
Conditions
- Tinnitus
- Tinnitus, Bilateral
Interventions
DeepTmsDevice
2 weeks deepTMS with different H-coils, 2000 pulses per session, Follow Up 10 weeks after treatment end
Primary outcomes
What the sponsor says the trial is designed to measure.
- Changes in Tinnitus BurdenTime frame: 12 weeks: from enrollment to the end of treatment after two weeks, plus Follow Up after 10 weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Psychiatry and Psychotherapy, Center of Neuromodulation / TMS, University Regensburg
Regensburg, Bavaria, Germany · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.